Jie Hu

1PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Apr 01, 2025
MET and NF2 alterations confer primary and early resistance to first-line alectinib treatment in ALK-positive non-small-cell lung cancer.

Jie Hu, Ning Ding, Xiaobo Xu

Pageof 1

Frequent Collaborators

1 joint publications

Yedan Chen